Ergoteles’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-78,216
| Closed | -$898K | – | 1268 |
|
|
2022
Q4 | $898K | Sell |
78,216
-13,031
| -14% | -$150K | 0.03% | 494 |
|
|
2022
Q3 | $1.15M | Buy |
+91,247
| New | +$1.15M | 0.04% | 433 |
|
|
2021
Q3 | – | Sell |
-32,062
| Closed | -$507K | – | 1220 |
|
|
2021
Q2 | $507K | Buy |
+32,062
| New | +$507K | 0.01% | 803 |
|